H. Tanji

566 total citations
22 papers, 347 citations indexed

About

H. Tanji is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, H. Tanji has authored 22 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in H. Tanji's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). H. Tanji is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). H. Tanji collaborates with scholars based in Japan, Netherlands and India. H. Tanji's co-authors include Yasuto Itoyama, Yasuto Itoyama, Michinao Mizugaki, Tsutomu Araki, Hiroyuki Arai, Hiroshi Sasaki, Yutaka Imai, Kiyohisa Sekizawa, Toshiaki Nakagawa and Kazuo Fujihara and has published in prestigious journals such as Brain Research, Movement Disorders and Journal of Internal Medicine.

In The Last Decade

H. Tanji

21 papers receiving 338 citations

Peers

H. Tanji
H Tanabe Japan
H. Tanji
Citations per year, relative to H. Tanji H. Tanji (= 1×) peers H Tanabe

Countries citing papers authored by H. Tanji

Since Specialization
Citations

This map shows the geographic impact of H. Tanji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Tanji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Tanji more than expected).

Fields of papers citing papers by H. Tanji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Tanji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Tanji. The network helps show where H. Tanji may publish in the future.

Co-authorship network of co-authors of H. Tanji

This figure shows the co-authorship network connecting the top 25 collaborators of H. Tanji. A scholar is included among the top collaborators of H. Tanji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Tanji. H. Tanji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koyama, Shingo, Toru Kawanami, H. Tanji, et al.. (2012). A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene. Clinical Neurology and Neurosurgery. 114(7). 1021–1023. 11 indexed citations
2.
Koyama, Shingo, Toru Kawanami, H. Tanji, et al.. (2011). Carpal tunnel syndrome as an initial manifestation in a case of transthyretin-related familial amyloid polyneuropathy with a novel A120T mutation. Clinical Neurology and Neurosurgery. 114(6). 707–709. 4 indexed citations
3.
Kikuchi, Akio, Atsushi Takeda, Kazuo Fujihara, et al.. (2003). Arg(184)his mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa‐responsive dystonia with parkinsonism: A case report. Movement Disorders. 19(5). 590–593. 17 indexed citations
4.
Araki, Tsutomu, H. Tanji, Mitsunobu Matsubara, et al.. (2001). Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. European Journal of Pharmaceutical Sciences. 12(3). 231–238. 54 indexed citations
5.
Araki, Tsutomu, H. Tanji, Hiroyuki Kato, et al.. (2000). Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain. European Neuropsychopharmacology. 10(5). 365–375. 15 indexed citations
6.
Nakagawa, Toshiaki, et al.. (2000). Silent cerebral infarction: a potential risk for pneumonia in the elderly. Journal of Internal Medicine. 247(2). 255–259. 61 indexed citations
7.
Araki, Tsutomu, H. Tanji, Kazuo Fujihara, et al.. (2000). Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. Journal of Neural Transmission. 107(8-9). 873–884. 18 indexed citations
8.
Araki, Tsutomu, H. Tanji, Kazuo Fujihara, H. Kato, & Yasuto Itoyama. (1999). Increases in [3H]FK-506 and [3H]L-NG-Nitro-Arginine Binding in the Rat Brain After Nigrostriatal Dopaminergic Denervation. Metabolic Brain Disease. 14(1). 21–31. 11 indexed citations
9.
Tanji, H., et al.. (1999). Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. European Journal of Pharmaceutical Sciences. 8(4). 261–267. 7 indexed citations
10.
Tanji, H., et al.. (1999). Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Brain Research. 824(2). 224–231. 31 indexed citations
11.
Tanji, H., et al.. (1999). Alteration of neurotensin receptors in MPTP-treated mice. Peptides. 20(7). 803–807. 12 indexed citations
12.
Tanji, H., et al.. (1998). Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. Journal of the Neurological Sciences. 160(2). 121–127. 20 indexed citations
13.
Tanji, H., H. Nagasawa, Tsutomu Araki, et al.. (1998). PET study of striatal fluorodopa uptake and dopamine D2 receptor binding in a patient with juvenile parkinsonism. European Journal of Neurology. 5(3). 243–248. 3 indexed citations
14.
Takahashi, Kazuhiro, Masahiko Sone, Fumitoshi Satoh, et al.. (1997). Presence of Adrenomedullin-Like Immunoreactivity in the Human Cerebrospinal Fluid. Peptides. 18(3). 459–461. 29 indexed citations
15.
Tanji, H., H. Nagasawa, M. Itoh, & Yasuto Itoyama. (1997). [PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].. PubMed. 55(1). 89–94. 1 indexed citations
16.
Tanji, H., Yasuto Itoyama, Hiroshi Saito, et al.. (1996). Brain 6-[ 18 F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography. Journal of the Neurological Sciences. 144(1-2). 70–76. 11 indexed citations
17.
Takahashi, Shoki, Takayuki Yamada, K. Ishii, et al.. (1992). MRI of anterior spinal artery syndrome of the cervical spinal cord. Neuroradiology. 35(1). 25–29. 19 indexed citations
18.
Tanji, H., et al.. (1988). [Effects of neurostimulation on the reversibility of neuronal function: experience of treatment for vegetative status].. PubMed. 16(2). 157–63. 9 indexed citations
19.
Tanji, H., Masahiko Watanabe, Kaori Masu, et al.. (1981). A case of intracranial mesenchymal chondrosarcoma. Changes observed by computed tomography before and after radiotherapy. 9(7). 843–848. 4 indexed citations
20.
Tanji, H., et al.. (1976). Intrathecal administration of CDP-choline into the lower lumbar subarachnoid space in two patients with post-traumatic akinetic mutism.. PubMed. 22(1-2). 31–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026